Cubist Systematic Strategies’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,776
| Closed | -$361K | – | 2187 |
|
|
2024
Q3 | $361K | Buy |
+12,776
| New | +$361K | ﹤0.01% | 1054 |
|
|
2024
Q2 | – | Sell |
-477,047
| Closed | -$14.5M | – | 2421 |
|
|
2024
Q1 | $14.5M | Buy |
477,047
+95,876
| +25% | +$2.91M | 0.08% | 142 |
|
|
2023
Q4 | $10.7M | Buy |
381,171
+166,723
| +78% | +$4.68M | 0.07% | 212 |
|
|
2023
Q3 | $5.82M | Sell |
214,448
-115,620
| -35% | -$3.14M | 0.04% | 399 |
|
|
2023
Q2 | $10.1M | Buy |
330,068
+307,854
| +1,386% | +$9.46M | 0.07% | 261 |
|
|
2023
Q1 | $800K | Sell |
22,214
-232,394
| -91% | -$8.37M | ﹤0.01% | 1588 |
|
|
2022
Q4 | $10.1M | Buy |
254,608
+132,176
| +108% | +$5.22M | 0.06% | 306 |
|
|
2022
Q3 | $4.92M | Buy |
122,432
+97,846
| +398% | +$3.93M | 0.03% | 836 |
|
|
2022
Q2 | $1.03M | Sell |
24,586
-82,818
| -77% | -$3.48M | 0.01% | 2096 |
|
|
2022
Q1 | $4.18M | Buy |
107,404
+68,970
| +179% | +$2.69M | 0.04% | 861 |
|
|
2021
Q4 | $1.53M | Sell |
38,434
-50,206
| -57% | -$2M | 0.01% | 1605 |
|
|
2021
Q3 | $3.2M | Sell |
88,640
-123,848
| -58% | -$4.48M | 0.04% | 715 |
|
|
2021
Q2 | $8.71M | Buy |
212,488
+173,983
| +452% | +$7.13M | 0.1% | 271 |
|
|
2021
Q1 | $1.68M | Buy |
38,505
+27,729
| +257% | +$1.21M | 0.02% | 1164 |
|
|
2020
Q4 | $539K | Sell |
10,776
-56,889
| -84% | -$2.85M | 0.01% | 1733 |
|
|
2020
Q3 | $2.85M | Buy |
67,665
+64,919
| +2,364% | +$2.73M | 0.04% | 692 |
|
|
2020
Q2 | $133K | Buy |
+2,746
| New | +$133K | ﹤0.01% | 2145 |
|